jueves, 28 de febrero de 2019

With positive results, Sarepta may have second gene therapy with potential

With positive results, Sarepta may have second gene therapy with potential



STAT Plus: With positive early results, Sarepta appears to have a second gene therapy with potential

By ADAM FEUERSTEIN


RUBY WALLAU FOR STAT
Sarepta Therapeutics announced early but encouraging results from its second gene therapy program targeting a rare, muscle-wasting disease.

No hay comentarios:

Publicar un comentario